6-K//Foreign company update
NeuroSense Therapeutics Ltd. 6-K
Accession 0001213900-25-113300
$NRSNCIK 0001875091other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 6:36 AM ET
Size
3.7 MB
Accession
0001213900-25-113300
Documents
- 6-Kea0266625-6k_neuro.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
- EX-99.1ea026662501ex99-1_neuro.htm
NOTICE AND PROXY STATEMENT FOR THE SPECIAL MEETING OF SHAREHOLDERS OF THE REGISTRANT SCHEDULED FOR DECEMBER 30, 2025
- EX-99.2ea026662501ex99-2_neuro.htm
PROXY CARD
- GRAPHICtneurosense_logo.jpg
GRAPHIC
- GRAPHICtneurosense_logo1.jpg
GRAPHIC
- GRAPHICtproxy_001.jpg
GRAPHIC
- GRAPHICtproxy_002.jpg
GRAPHIC
Issuer
NeuroSense Therapeutics Ltd.
CIK 0001875091
Entity typeother
IncorporatedIsrael
Related Parties
1- filerCIK 0001875091
Filing Metadata
- Form type
- 6-K
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 6:36 AM ET
- Size
- 3.7 MB